Abstract
Background: Electronic data capture technologies, such as interactive voice response (IVR) systems, are emerging as important alternatives for collecting patient-reported outcome data.
Objective: The objective of this study was to assess the test-retest reliability of an IVR version of the EQ-5D.
Methods: Outpatient cancer clinic patients (n= 127) were asked to complete the IVR-based EQ-5D twice, 2 days apart. The analyses tested for mean differences (paired t-test) and test-retest reliability (intraclass correlation coefficient [ICC]) to assess measurement stability over time. Equivalence of the means was established if the 95% confidence interval (CI) was within the minimally important difference (MID) interval; namely −0.035 to 0.035 for the EQ-5D index and −3.0 to 3.0 for the visual analog scale (i.e. EQ VAS). Adequacy of the ICC was established by testing whether it differed from a value of 0.70.
Results: Both administrations were completed per protocol by 114 subjects (EQ-5D index) and 110 subjects (EQ VAS). For the EQ-5D index, the means (SD) of the first and second administrations were 0.871 (0.14) and 0.871 (0.15), respectively. The 95% CI of the mean difference was −0.013, 0.013, within the equivalence interval. The ICC was 0.876 (95% lower bound of 0.826) and was significantly different from 0.70. The EQ VAS means (SD) were 81.3 (17.5) and 80.8 (17.5), respectively. The 95% CI of the mean difference was −0.598, 1.617, within the equivalence interval. The EQ VAS ICC was 0.944 (95% lower bound of 0.919) and was significantly greater than 0.70.
Conclusion: This analysis provides substantial evidence that the scores obtained from the IVR version of the EQ-5D are reliable upon repeated administrations.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.2165%2F11595840-000000000-00000/MediaObjects/40271_2012_5010021_Tab1.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.2165%2F11595840-000000000-00000/MediaObjects/40271_2012_5010021_Tab2.jpg)
References
Konopka A. The power of ePRO. PharmaVOICE 2005 Nov; 40-4
Coons SJ, Gwaltney CJ, Hays RD, et al. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force Report. Value Health 2009; 12(4): 419–29
Gwaltney CJ, Shields AL, Shiffman S. Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review. Value Health 2008; 11: 322–33
Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001; 33: 337–43
Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 model. Med Care 2005; 43: 203–20
Lundy JJ, Coons SJ. Measurement equivalence of interactive voice response and paper versions of the EQ-5D in a cancer patient sample. Value Health 2011; 14(6): 867–71
Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials 1981; 2: 93–113
Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 2005; 14: 1523–32
Pickard AS, Neary MP, Cella D. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes 2007; 5: 70
Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw-Hill, 1994
Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. 3rd ed. New York: Oxford University Press, 2003
SPSS Inc. SPSS [computer program]. Version 16.0. Chicago (IL): SPSS Inc., 2007
Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86: 420–8
McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients [published erratum appears in Psychol Methods 1996; 1 (4): 390]. Psychol Methods 1996; 1(1): 1, 30–46
Fransen M, Edmonds J. Reliability and validity of the EuroQol in patients with osteoarthritis of the knee. Rheumatology 1999; 38: 807–13
Harper R, Brazier JE, Waterhouse JC, et al. Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. Thorax 1997; 52: 879–87
Macran S. Test-retest performance of EQ-5D. In: Brooks R, Rabin R, de Charro F, editors. The measurement and valuation of health status using EQ-5D: a European perspective. Dordrecht: Kluwer Academic Publishers, 2003: 43–54
Luo N, Chew L-H, Fong K-Y, et al. Do English and Chinese versions of the EQ-5D demonstrate measurement equivalence? An exploratory study. Health Qual Life Outcomes 2003; 1: 7 [online]. Available from URL: http://www.hqlo.com/content/1/1/7 [Accessed 2010 Sep 13]
Gao F, Ng GY, Cheung YB, et al. The Singaporean English and Chinese versions of the EQ-5D achieved measurement equivalence in cancer patients. J Clinical Epidemiol 2009; 62: 206–13
Acknowledgments
The data used for this research were collected as part of a study funded by ClinPhone Plc (now Perceptive Informatics). Additional support was provided by the Arizona Cancer Center Support Grant (grant number CA023074) from the National Cancer Institute. The authors gratefully acknowledge the staff and facility support provided by the University of Arizona College of Pharmacy and the Arizona Cancer Center’s Behavioral Measurements Shared Service.
The authors were employed by the University of Arizona at the time the data for this study were collected. The authors have no financial interest in Perceptive Informatics or ClinPhone Plc. The views expressed in this paper are those of the authors and do not necessarily represent the views of Perceptive Informatics, the University of Arizona, or Critical Path Institute.
Author information
Authors and Affiliations
Corresponding author
Additional information
Key points for decision makers
• Electronic data capture (EDC) technologies are increasingly used to collect patient-reported outcomes (PROs)
• When PRO instruments are migrated to EDC platforms, the reliability of the scores obtained via EDC should be assessed
• The EQ-5D is a widely used preference-based health status measure
• Our results demonstrate the reliability of the interactive voice response version of the EQ-5D upon repeated administration
Rights and permissions
About this article
Cite this article
Lundy, J.J., Coons, S.J. Test-Retest Reliability of an Interactive Voice Response Version of the EQ-5D in a Sample of Cancer Survivors. Patient 5, 21–26 (2012). https://doi.org/10.2165/11595840-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11595840-000000000-00000